Stockholm, February 25, 2011 — NASDAQ OMX (NASDAQ: NDAQ) announces that trading in Kancera AB (short name: KAN) shares will commence today, February 25, on First North at NASDAQ OMX Stockholm. Kancera belongs to the Health Care sector and is the second company to be admitted to trading on First North in 2011.
Kancera AB is a Swedish-based biotechnology company focusing on the development and sales of drugs for treating leukemia and solid tumors.
Jenny Rosberg, Senior Vice President at NASDAQ OMX said, “We welcome Kancera to First North, one of Europe’s most liquid growth markets. Kancera will make a great addition to Nordic and international trading members looking for investment opportunities in the Health Care sector.”
Kancera has appointed Remium AB as Certified Adviser.
Carl Norell +46 (8) 405 66 39
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.